GLUT1 Monoclonal Antibody (SPM498) | Invitrogen MA5-11315 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

GLUT1 Monoclonal Antibody (SPM498)

catalog :

MA5-11315

quantity :

500 µL

price :

US 500

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

SPM498

reactivity :

human, mouse, rat

application :

immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section

citations: 19

Reference
Rajani R, Ratelade J, Domenga Denier V, Hase Y, Kalimo H, Kalaria R, et al. Blood brain barrier leakage is not a consistent feature of white matter lesions in CADASIL. Acta Neuropathol Commun. 2019;7:187 pubmed publisher
Lee H, Leslie F, Azarin S. A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl2. J Biol Eng. 2018;12:12 pubmed publisher
Al Ahmad A. Comparative study of expression and activity of glucose transporters between stem cell-derived brain microvascular endothelial cells and hCMEC/D3 cells. Am J Physiol Cell Physiol. 2017;313:C421-C429 pubmed publisher
Fan J, Mei J, Zhang M, Yuan F, Li S, Yu G, et al. Clinicopathological significance of glucose transporter protein-1 overexpression in human osteosarcoma. Oncol Lett. 2017;14:2439-2445 pubmed publisher
Vatine G, Al Ahmad A, Barriga B, Svendsen S, Salim A, Garcia L, et al. Modeling Psychomotor Retardation using iPSCs from MCT8-Deficient Patients Indicates a Prominent Role for the Blood-Brain Barrier. Cell Stem Cell. 2017;20:831-843.e5 pubmed publisher
Stebbins M, Wilson H, Canfield S, Qian T, Palecek S, Shusta E. Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells. Methods. 2016;101:93-102 pubmed publisher
Kong G, Hofman M, Murray W, Wilson S, Wood P, Downie P, et al. Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma. J Pediatr Hematol Oncol. 2016;38:87-96 pubmed publisher
Kwon O, Park J, Ko G, Seo J, Jeong B, Kang K, et al. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma. Head Neck. 2015;37:505-10 pubmed publisher
Malin D, Strekalova E, Petrovic V, Deal A, Al Ahmad A, Adamo B, et al. ?B-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res. 2014;20:56-67 pubmed publisher
Chang M, Oh S, Jung E, Park J, Jeon H, Lee T, et al. High-risk human papillomavirus load and biomarkers in cervical intraepithelial neoplasia and cancer. APMIS. 2014;122:427-36 pubmed publisher
Kim B, Cho H, Chung J, Conway C, Ylaya K, Kim J, et al. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. J Transl Med. 2013;11:185 pubmed publisher
Kashyap R, Lau E, George A, Seymour J, Lade S, Hicks R, et al. High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2013;40:1330-6 pubmed publisher
Petito R, Amadeu T, Pascarelli B, Jardim M, Vital R, Antunes S, et al. Transforming growth factor-?1 may be a key mediator of the fibrogenic properties of neural cells in leprosy. J Neuropathol Exp Neurol. 2013;72:351-66 pubmed publisher
Lee A, Gown A, Churg A. IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations. Am J Surg Pathol. 2013;37:421-6 pubmed publisher
Partanen T, Vuola P, Jauhiainen S, Lohi J, Salminen P, Pitkaranta A, et al. Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformations. Angiogenesis. 2013;16:137-46 pubmed publisher
Renkonen S, Heikkila P, Haglund C, Makitie A, Hagstrom J. Tenascin-C, GLUT-1, and syndecan-2 expression in juvenile nasopharyngeal angiofibroma: correlations to vessel density and tumor stage. Head Neck. 2013;35:1036-42 pubmed publisher
Li J, Koike J, Kugoh H, Arita M, Ohhira T, Kikuchi Y, et al. Down-regulation of MutS homolog 3 by hypoxia in human colorectal cancer. Biochim Biophys Acta. 2012;1823:889-99 pubmed publisher
Sasaki H, Shitara M, Yokota K, Hikosaka Y, Moriyama S, Yano M, et al. Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas. Mol Med Rep. 2012;5:599-602 pubmed publisher
Kim J, Kwon G, Roh J, Choi S, Nam S, Kim S, et al. Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation. J Korean Med Sci. 2011;26:1277-85 pubmed publisher

product information

Product Type :

Antibody

Product Name :

GLUT1 Monoclonal Antibody (SPM498)

Catalog # :

MA5-11315

Quantity :

500 µL

Price :

US 500

Clonality :

Monoclonal

Purity :

Protein A/G

Host :

Mouse

Reactivity :

Human, Mouse, Rat

Applications :

Flow Cytometry: 1 µg/ 10^6 cells, Immunocytochemistry: 1-5 µg/mL, Immunofluorescence: 1-5 µg/mL, Immunohistochemistry (Frozen): 1:200, Immunohistochemistry (Paraffin): 1:200

Species :

Human, Mouse, Rat

Clone :

SPM498

Isotype :

IgG1, kappa

Storage :

-20° C, Avoid Freeze/Thaw Cycles

Description :

Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses.

Immunogen :

A synthetic peptide derived from C-terminal of human GLUT-1

Format :

Liquid

Applications w/Dilutions :

Flow Cytometry: 1 µg/ 10^6 cells, Immunocytochemistry: 1-5 µg/mL, Immunofluorescence: 1-5 µg/mL, Immunohistochemistry (Frozen): 1:200, Immunohistochemistry (Paraffin): 1:200

Aliases :

choreoathetosis/spasticity, episodic (paroxysmal choreoathetosis/spasticity); CSE; DYT17; DYT18; DYT9; EIG12; glucose transporter glut1; Glucose transporter type 1, erythrocyte/brain; glucose transporter type I; GLUT; Glut1; GLUT-1; GLUT1DS; GLUTB; GT1; GTG1; Gtg3; HepG2 glucose transporter; HTLVR; human T-cell leukemia virus (I and II) receptor; MGC141895; MGC141896; PED; RATGTG1; receptor for HTLV-1 and HTLV-2; SDCHCN; SLC2A1; solute carrier family 2 (facilitated glucose transporter), member 1; Solute carrier family 2 a 1 (facilitated glucose transporter) brain; solute carrier family 2 member 1; solute carrier family 2, facilitated glucose transporter member 1; solute carrier family 2, member 1